# ACADIA PHARMACEUTICALS INC (ACAD) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ACADIA PHARMACEUTICALS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ACAD/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-072519 (https://www.sec.gov/Archives/edgar/data/1070494/000119312526072519/acad-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ACAD/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-029253 (https://www.sec.gov/Archives/edgar/data/1070494/000095017025029253/acad-20241231.htm)
- [FY 2023 MD&A](/company/ACAD/mda/fy2023/): filed 2024-02-28; accession 0000950170-24-021473 (https://www.sec.gov/Archives/edgar/data/1070494/000095017024021473/acad-20231231.htm)
- [FY 2022 MD&A](/company/ACAD/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-004757 (https://www.sec.gov/Archives/edgar/data/1070494/000095017023004757/acad-20221231.htm)
- [FY 2021 MD&A](/company/ACAD/mda/fy2021/): filed 2022-03-01; accession 0000950170-22-002392 (https://www.sec.gov/Archives/edgar/data/1070494/000095017022002392/acad-20211231.htm)

Back to /company/ACAD/